Galmed Pharmaceuticals Ltd. (EOCN): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$4.0K
Year ended 2022-12-31
-30.7%
3-year compound annual growth
-19.7%
5-year compound annual growth
-18.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $4.0K | -63.6% | 2025-04-02, From 2022-01-01 |
| 2021-12-31 | $11.0K | -75.0% | 2024-04-04, From 2021-01-01 |
| 2020-12-31 | $44.0K | +266.7% | 2023-03-29, From 2020-01-01 |
| 2019-12-31 | $12.0K | -86.7% | 2022-05-02, From 2019-01-01 |
| 2018-12-31 | $90.0K | +650.0% | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | $12.0K | -29.4% | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | $17.0K | -89.3% | 2019-03-13, From 2016-01-01 |
| 2015-12-31 | $159.0K | -79.4% | 2018-03-13, From 2015-01-01 |
| 2014-12-31 | $770.0K | n/m | 2017-03-23, From 2014-01-01 |
| 2013-12-31 | $13.0K | -59.4% | 2016-03-22, From 2013-01-01 |
| 2012-12-31 | $32.0K | n/a | 2015-03-31, From 2012-01-01 |